THALLOUS CHLORIDE TI-201 INJECTION SOLUTION

Nchi: Kanada

Lugha: Kiingereza

Chanzo: Health Canada

Viambatanisho vya kazi:

THALLIUM CHLORIDE(TI 201)

Inapatikana kutoka:

CURIUM CANADA INC

ATC kanuni:

V09GX01

INN (Jina la Kimataifa):

THALLIUM 201 TL CHLORIDE

Kipimo:

37MBq

Dawa fomu:

SOLUTION

Tungo:

THALLIUM CHLORIDE(TI 201) 37MBq

Njia ya uendeshaji:

INTRAVENOUS

Vitengo katika mfuko:

10ML

Dawa ya aina:

Schedule C

Eneo la matibabu:

ROENTGENOGRAPHY

Bidhaa muhtasari:

Active ingredient group (AIG) number: 0152598004; AHFS:

Idhini hali ya:

APPROVED

Idhini ya tarehe:

2018-12-07

Tabia za bidhaa

_Page 1 of 21 _
PRODUCT MONOGRAPH
THALLOUS CHLORIDE TL 201 INJECTION
Thallium Tl 201
Solution for intravenous use containing per mL, 37 megabecquerels (1
millicurie)
Thallous Chloride Tl 201 at calibration time.
Radiodiagnostic Agent
Curium Canada Inc.
2572 boul. Daniel-Johnson, Suite 245-249
Laval, QC, H7T-2R3
CANADA
Date of Revision: April 26
th
, 2019
CONTROL NUMBER: 225111
_Page 2 of 21 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
DESCRIPTION...................................................................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
5
CONTRAINDICATIONS
..................................................................................................
6
WARNINGS AND PRECAUTIONS
.................................................................................
6
ADVERSE REACTIONS
...................................................................................................
9
DRUG INTERACTIONS
...................................................................................................
9
DOSAGE AND ADMINISTRATION
.............................................................................
10
RADIATION DOSIMETRY
............................................................................................
12
OVERDOSAGE
...............................................................................................................
13
ACTION AND CLINICAL PHARMACOLOGY
........................................................... 13
STORAGE AND STABILITY
.........................................................................................
14
SPECIAL HANDLING INSTRUCTIONS
......................................................................
15
DOSAGE FORMS, COMPOSITION AND PACKAGING
.......................